Iga Nephropathy
📧 Sign up to get email alerts when something new happens for Iga Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression [Phase 3]
Phase 3 pilot study results for ACTH in progressive IgA nephropathy with high risk of progression have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Pilot Study of Velcade® in IgA Nephropathy [Phase 4]
Pilot Phase 4 study of Velcade in IgA nephropathy has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Efficacy and Safety of Losartan in Children With Ig A Nephropathy [Phase 3]
Phase 3 trial update evaluating efficacy and safety of losartan in children with IgA nephropathy (IgA glomerulonephritis) completed.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Fecal Microbiota Transplantation for Refractory IgA Nephropathy [Phase 2]
Phase 2 clinical trial update on fecal microbiota transplantation for refractory IgA nephropathy.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy [Phase 2]
Phase 2 trial evaluating hydroxychloroquine sulfate for reducing proteinuria in IgA nephropathy has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy [Phase 4]
A Phase 4 trial update suggests hydroxychloroquine sulfate may alleviate persistent proteinuria in primary IgA nephropathy, though status is…
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration [Phase 2, Phase 3]
Phase 2/3 trial update on blisibimod for IgA nephropathy, including at-home subcutaneous administration.
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy [Phase 4]
This document provides extended follow-up data from a Phase 4 study of prednisone plus cyclophosphamide in patients with advanced IgA nephro…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy [Phase 4]
This document reports an update on a Phase 4 trial evaluating the combination of mycophenolate mofetil and corticosteroid for advanced IgA n…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy [Phase 4]
Phase 4 study evaluating rituximab in progressive IgA nephropathy completed; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers [NA]
A completed clinical trial assessed whether adding oral calcitriol provides additional renoprotective effects for patients with IgA nephropa…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of Abelmoschus Manihot for IgA Nephropathy; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN) [NA]
A multi-site prospective study assessing the efficacy and safety of mycophenolate mofetil (MMF) for proliferative IgA nephropathy has comple…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study [Phase 4]
Phase 4 self-controlled study assessing hydroxychloroquine sulfate for reducing proteinuria in patients with IgA nephropathy; the trial has …
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Rituximab in Recurrent IgA Nephropathy [Phase 4]
Phase 4 clinical trial update studying Rituximab for recurrent IgA nephropathy.
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease [Phase 2]
This update reports completion of a Phase 2 study evaluating Nefecon in patients with Primary IgA Nephropathy at risk of progressing to end-…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy [Phase 3]
Phase 3 trial comparing supportive therapy versus immunosuppressive therapy for progressive IgA nephropathy completed.
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Biomarkers for the Progression of IgA Nephropathy
A completed clinical trial from Istanbul University studied biomarkers for the progression of IgA nephropathy and related glomerular disease…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) Nephropathy [NA]
The trial update indicates completion of a clinical study studying autonomic nervous system functioning and renal function in IgA nephropath…
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients
A completed clinical trial update examining the relationship between periostin levels and renal pathology in chronic kidney disease, includi…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade [Phase 4]
Phase 4 clinical trial evaluating aliskiren for proteinuric IgA nephropathy despite angiotensin blockade has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis [NA]
The clinical trial evaluating TW for IgA nephropathy with asymptomatic abnormal urinalysis has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes. [Phase 2]
Phase 2 clinical trial evaluating steroid therapy for IgA nephropathy with active pathological changes; current status is not provided.
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy [Phase 3]
Phase 3 trial of mycophenolate mofetil in IgA nephropathy was terminated with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of tacrolimus in IgA nephropathy in Korean patients has completed.